Xarelto Bellwether Trials Scheduled

Defective Drugs
Bellwether Trials

By Sandra Dalton, Staff Writer

Four Xarelto bellwether trials, in multidistrict litigation (MDL) 2592, have been scheduled for 2017. There are more than 2,800 cases in the MDL, which is being overseen by U.S. District Judge Eldon E. Fallon. 40 bellwether cases have been selected and Judge Fallon asked that four of the bellwether cases be chosen and scheduled so that everyone involved can get a better idea of how jurors will respond to the evidence and testimony.

Dates Set in Xarelto Bellwether Trials

The dates are:

  • February 6, 2017
  • March 13, 2017
  • April 24, 2017
  • May 30, 2017

The dates are set, but the cases have not yet been selected. The first two trials will be held in the U.S. District Court for the Eastern District of Louisiana. The second two are tentatively set for Mississippi and Texas in as-yet unspecified federal district courts, and those locations may change.

Common Allegations

Consolidating large numbers of lawsuits into multidistrict litigation can make for a faster and smoother process for everyone involved. The lawsuits remain separate, but certain aspects can be combined. This only works when the lawsuits are very similar. In the Xarelto MDL the plaintiffs allege that the drug can cause uncontrollable bleeding and that defendants Bayer AG and Janssen Pharmaceuticals failed to warn doctors and consumers of that risk, robbing them of the chance to make an informed choice that could have allowed them to avoid injury.

If you or someone you love has been harmed by Xarelto, please talk to an experienced defective drug attorney right away to learn more about your rights and potential compensation.

Add new comment